In re: Sensipar Cinacalcet Hydrochloride Tablets
| In re: SENSIPAR CINACALCET HYDROCHLORIDE TABLETS ANTITRUST LITIGATION |
| UFCW LOCAL 1500 WELFARE FUND, CESAR CASTILLO LLC, KPH HEALTHCARE SERVICES INC and TEAMSTERS WESTERN REGION & LOCAL 177 HEALTH CARE PLAN |
| TEVA PHARMACEUTICALS USA INC, WATSON LABORATORIES INC, ACTAVIS PHARMA INC and AMGEN INC |
| TEAMSTERS LOCAL 237 WELFARE FUND and TEAMSTERS LOCAL 237 RETIREES BENEFIT FUND |
| 23-2214 |
| July 11, 2023 |
| U.S. Court of Appeals, Third Circuit |
| Antitrust |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 24, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 22 BRIEFING NOTICE ISSUED. Brief on behalf of Appellants Actavis Pharma Inc, Amgen Inc, Teva Pharmaceuticals USA Inc and Watson Laboratories Inc due on or before 10/03/2023. Appendix due on or before 10/03/2023. [23-2213, 23-2214, 23-2215, 23-2216, 23-2217] (JK) [Entered: 08/24/2023 01:21 PM] |
| Filing 21 ECF FILER: ENTRY OF APPEARANCE from Brian P. Egan on behalf of Appellant(s) Amgen Inc.. [23-2214] (BPE) [Entered: 08/01/2023 12:53 PM] |
| Filing 20 ECF FILER: ENTRY OF APPEARANCE from Jack B. Blumenfeld on behalf of Appellant(s) Amgen Inc.. [23-2214] (JBB) [Entered: 08/01/2023 12:46 PM] |
| Filing 19 ECF FILER: LETTER on behalf of Appellant Amgen Inc. Appellant Amgen Inc will adopt the Civil Information Statement (Dkt. 10), Concise Summary of the Case (Dkt. 11), and Transcript Purchase Order Form (Dkt. 15) on behalf of Appellants Actavis Pharma Inc, Teva Pharmaceuticals USA Inc and Watson Laboratories Inc. Certificate of Service dated 07/28/2023.Service made by ECF. This document will be SENT TO THE MERITS PANEL if/when applicable. [23-2214] (AEJ) [Entered: 07/28/2023 04:55 PM] |
| Filing 18 ECF FILER: DISCLOSURE STATEMENT on behalf of Appellant Amgen Inc. [23-2214] (AEJ) [Entered: 07/28/2023 04:51 PM] |
| Filing 17 ECF FILER: ENTRY OF APPEARANCE from Ashley E. Johnson on behalf of Appellant(s) Amgen, Inc.. [23-2214] (AEJ) [Entered: 07/28/2023 04:47 PM] |
| Filing 16 ECF FILER: ENTRY OF APPEARANCE from Karen E. Keller on behalf of Appellant(s) Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc., Actavis Pharma Inc.. [23-2214] (KEK) [Entered: 07/28/2023 10:05 AM] |
| Filing 15 ECF FILER: Transcript Purchase Order Form (Part 1) filed by Appellants Actavis Pharma Inc, Teva Pharmaceuticals USA Inc and Watson Laboratories Inc advising this court that transcripts are already on file in the District Court. [23-2214, 23-2215, 23-2216, 23-2217]--[Edited 07/28/2023 by JK] (HB) [Entered: 07/27/2023 04:52 PM] |
| Filing 14 ECF FILER: DISCLOSURE STATEMENT on behalf of Appellant Watson Laboratories Inc. [23-2214, 23-2217, 23-2216, 23-2215]--[Edited 07/28/2023 by JK] (HB) [Entered: 07/27/2023 04:43 PM] |
| Filing 13 ECF FILER: DISCLOSURE STATEMENT on behalf of Appellant Teva Pharmaceuticals USA Inc . [23-2214, 23-2215, 23-2216, 23-2217]--[Edited 07/28/2023 by JK] (HB) [Entered: 07/27/2023 04:40 PM] |
| Filing 12 ECF FILER: DISCLOSURE STATEMENT on behalf of Appellant Actavis Pharma Inc. [23-2214, 23-2215, 23-2216, 23-2217]--[Edited 07/28/2023 by JK] (HB) [Entered: 07/27/2023 04:36 PM] |
| Filing 11 ECF FILER: Concise Summary of the Case filed by Appellants Actavis Pharma Inc, Teva Pharmaceuticals USA Inc and Watson Laboratories Inc. [23-2214, 23-2215, 23-2216, 23-2217]--[Edited 07/28/2023 by JK] (HB) [Entered: 07/27/2023 04:31 PM] |
| Filing 10 ECF FILER: CIVIL INFORMATION STATEMENT on behalf of Appellants Actavis Pharma Inc, Teva Pharmaceuticals USA Inc and Watson Laboratories Inc. [23-2214, 23-2215, 23-2216, 23-2217]--[Edited 07/28/2023 by JK] (HB) [Entered: 07/27/2023 04:25 PM] |
| Filing 9 ECF FILER: ENTRY OF APPEARANCE from Henninger S. Bullock on behalf of Appellant(s) Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc., Actavis Pharma Inc.. [23-2214, 23-2215, 23-2216, 23-2217]--[Edited 07/28/2023 by JK] (HB) [Entered: 07/27/2023 04:16 PM] |
| Filing 8 ECF FILER: DISCLOSURE STATEMENT on behalf of Appellees Cesar Castillo LLC, UFCW Local 1500 Welfare Fund, KPH Healthcare Services Inc, Teamsters Local 237 Retirees Benefit Fund, Teamsters Local 237 Welfare Fund and Teamsters Western Region & Local 177 Health Care Plan in 23-2214, 23-2215, 23-2216, 23-2217. [23-2214, 23-2215, 23-2216, 23-2217] (ICB) [Entered: 07/27/2023 02:14 PM] |
| Filing 7 ECF FILER: ENTRY OF APPEARANCE from Ian Connor Bifferato on behalf of Appellee(s) UFCW Local 1500 Welfare Fund, Teamsters Local 237 Retirees' Benefit Fund, Teamsters Local 237 Welfare Fund, and Teamsters Western Region & Local 177 Health Care Plan. [23-2214, 23-2215, 23-2216, 23-2217] (ICB) [Entered: 07/27/2023 02:09 PM] |
| Filing 6 FOLLOW UP LETTER to Ian C. Bifferato, Esq. for Teamsters Western Region & Local 177 Health Care Plan, Joseph J. DePalma, Esq. for Teamsters Local 237 Welfare Fund and Teamsters Local 237 Retirees Benefit Fund, Scott M. Tucker, Esq. for KPH Healthcare Services Inc and Cesar Castillo LLC and Ned C. Weinberger, Esq. for UFCW Local 1500 Welfare Fund in 23-2214, 23-2215, 23-2216, 23-2217 requesting the following document(s): Appearance Form on or before 08/10/2023. Disclosure Statement on or before 08/10/2023. [23-2214, 23-2215, 23-2216, 23-2217] (JK) [Entered: 07/27/2023 01:36 PM] |
| Filing 5 FOLLOW UP LETTER to Jack B. Blumenfeld, Esq. for Teva Pharmaceuticals USA Inc, Amgen Inc, Watson Laboratories Inc and Actavis Pharma Inc, Henninger Bullock, Esq. for Teva Pharmaceuticals USA Inc, Watson Laboratories Inc and Actavis Pharma Inc, Brian P. Egan, Esq. for Teva Pharmaceuticals USA Inc, Amgen Inc, Watson Laboratories Inc and Actavis Pharma Inc, Nathan R. Hoeschen, Esq. for Teva Pharmaceuticals USA Inc, Amgen Inc, Watson Laboratories Inc and Actavis Pharma Inc, Ashley E. Johnson, Esq. for Amgen Inc, Karen E. Keller, Esq. for Teva Pharmaceuticals USA Inc, Amgen Inc, Watson Laboratories Inc and Actavis Pharma Inc, Miranda R. Onnen, Esq. for Teva Pharmaceuticals USA Inc, Watson Laboratories Inc and Actavis Pharma Inc, NIketa K. Patel, Esq. for Teva Pharmaceuticals USA Inc, Watson Laboratories Inc and Actavis Pharma Inc, Nicholas E. Rodriguez, Esq. for Teva Pharmaceuticals USA Inc, Watson Laboratories Inc and Actavis Pharma Inc, John W. Shaw, Esq. for Teva Pharmaceuticals USA Inc, Amgen Inc, Watson Laboratories Inc and Actavis Pharma Inc, Richard A. Spehr, Esq. for Teva Pharmaceuticals USA Inc, Watson Laboratories Inc and Actavis Pharma Inc and Eric J. Stock, Esq. for Amgen Inc in 23-2214 requesting the following document(s): Appearance Form on or before 08/10/2023. Disclosure Statement on or before 08/10/2023. Information Statement on or before 08/10/2023. Concise Summary on or before 08/10/2023. Transcript Purchase Order on or before 08/10/2023. [23-2214, 23-2215, 23-2216, 23-2217] (JK) [Entered: 07/27/2023 01:19 PM] |
| Filing 4 Case has been listed at the convenience to the Court, and will be scheduled after briefing has been completed. Calendar Clerk: AR. [23-2213, 23-2214, 23-2215, 23-2216, 23-2217] (AR) [Entered: 07/17/2023 03:45 PM] |
| Filing 3 CLERK ORDER, The actions at Nos. 23-2213, 23-2214, 23-2215, 23-2216, and 23-2217 are hereby consolidated for all purposes. [23-2213, 23-2214, 23-2215, 23-2216, 23-2217] (JK) [Entered: 07/11/2023 04:24 PM] |
| Filing 2 RECORD available on District Court CM/ECF. (JK) [Entered: 07/11/2023 01:58 PM] |
| Filing 1 CIVIL CASE DOCKETED. Notice filed by Appellants Actavis Pharma Inc, Amgen Inc, Teva Pharmaceuticals USA Inc and Watson Laboratories Inc in District Court No. 1-19-cv-00369. Transferred from Misc. Docket No. 23-8020. (JK) [Entered: 07/11/2023 01:54 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
